Publication:
STatin TReatment for COVID- 19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID- 19 infection

Simple item page
dc.contributor.authorDelfino, Carlos
dc.contributor.authorCarcel, Cheryl
dc.contributor.authorLin, Xiaolei
dc.contributor.authorMunoz Venturelli, Paula
dc.contributor.authorNaismith, Sharon
dc.contributor.authorWoodward, Mark
dc.contributor.authorPeters, Ruth
dc.contributor.authorWijesuriya, Nirupama
dc.contributor.authorLaw, Meng
dc.contributor.authorHarding, Ian
dc.contributor.authorWang, Xia
dc.contributor.authorElliott, Julian
dc.contributor.authorLeder, Karin
dc.contributor.authorHutchings, Owen
dc.contributor.authorStecher, Ximena
dc.contributor.authorZoungas, Sophia
dc.contributor.authorAnderson, Craig
dc.date.accessioned2026-08-06T17:07:43Z
dc.date.available2026-08-06T17:07:43Z
dc.date.issued2025
dc.description.abstractIntroduction Increasing awareness of the high frequency, wide spectrum and disabling nature of symptoms that can persist following COVID-19 infection has prompted the investigation of management strategies. Our study aims to determine the effectiveness of atorvastatin on cognitive function, physical activity, mood, health-related quality of life and features of neurovascular impairment and neuroinflammation in adults with ongoing neurological symptoms after COVID-19 infection. Methods and analysis The STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy study is an ongoing international, investigator-initiated and conducted, multicentre, prospective, randomised, open label, blinded endpoint trial with fixed time points for outcome assessments. A total of 410 participants with long covid neurological symptoms were planned to be randomly assigned to either the intervention group to receive 40 mg atorvastatin for 12 months or to a control group of no treatment, on top of usual care. Ethics and dissemination This study protocol was designed, implemented and reported, in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice, the National Health and Medical Research Council of Australia, the National Statement on Ethical Conduct in Human Research and with the ethical principles laid down in the World Medical Association Declaration of Helsinki. Central ethics committee approval was obtained from Sydney Local Health District Royal Prince Alfred Hospital Ethics (No: X21-0113 and 2021/ETH00777 10) in Australia. Site-specific ethics committee approvals were obtained elsewhere before any local study activities. All participants provided written informed consent.
dc.description.versionVersión Aceptada
dc.identifier.citationDelfino C, Carcel C, Lin X, et al. STatin TReatment for COVID- 19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID- 19 infection. BMJ Open 2025;15:e089382. doi:10.1136/ bmjopen-2024-089382
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2024-089382
dc.identifier.urihttps://hdl.handle.net/11447/10969
dc.language.isoen
dc.subjectCOVID-19
dc.subjectClinical Protocols
dc.subjectPost-Acute COVID-19 Syndrome
dc.subjectProtocols & guidelines
dc.titleSTatin TReatment for COVID- 19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID- 19 infection
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceBMJ Journals
dspace.entity.typePublication
relation.isAuthorOfPublication77bec604-0a16-4d85-aaee-734c326e253a
relation.isAuthorOfPublication.latestForDiscovery77bec604-0a16-4d85-aaee-734c326e253a

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
STatin TReatment for COVID- 19 to Optimise NeuroloGical recovERy (STRONGER).pdf
Size:
631.27 KB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services